959
Views
58
CrossRef citations to date
0
Altmetric
Review

Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease

&
Pages 47-57 | Received 01 Apr 2016, Accepted 17 Jun 2016, Published online: 01 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Colm Lannon-Boran, Caoimhe Hannigan, Joanna McHugh Power, Jonathan Lambert & Michelle Kelly. (2023) The effect of mindfulness-based intervention on cognitively unimpaired older adults’ cognitive function and sleep quality: a systematic review and meta-analysis. Aging & Mental Health 0:0, pages 1-13.
Read now
Zhijun Yang, Dan-Dan Zhou, Si-Yu Huang, Ai-Ping Fang, Hua-Bin Li & Hui-Lian Zhu. (2023) Effects and mechanisms of natural products on Alzheimer’s disease. Critical Reviews in Food Science and Nutrition 63:18, pages 3168-3188.
Read now
Khushboo Govind Faldu & Jigna Samir Shah. (2022) Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis. Expert Review of Molecular Diagnostics 22:7, pages 681-703.
Read now
Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant, Marcel M. Verbeek, Bruno Dubois, Pieter Jelle Visser, Kurt A. Jellinger, Sebastiaan Engelborghs, Alfredo Ramirez, Lucilla Parnetti, Clifford R. Jack$suffix/text()$suffix/text(), Charlotte E. Teunissen, Harald Hampel, Alberto Lleó, Frank Jessen, Lidia Glodzik, Mony J. de Leon, Anne M. Fagan, José Luis Molinuevo, Willemijn J. Jansen, Bengt Winblad, Leslie M. Shaw, Ulf Andreasson, Markus Otto, Brit Mollenhauer, Jens Wiltfang, Martin R. Turner, Inga Zerr, Ron Handels, Alexander G. Thompson, Gunilla Johansson, Natalia Ermann, John Q. Trojanowski, Ilker Karaca, Holger Wagner, Patrick Oeckl, Linda van Waalwijk van Doorn, Maria Bjerke, Dimitrios Kapogiannis, H. Bea Kuiperij, Lucia Farotti, Yi Li, Brian A. Gordon, Stéphane Epelbaum, Stephanie J. B. Vos, Catharina J. M. Klijn, William E. Van Nostrand, Carolina Minguillon, Matthias Schmitz, Carla Gallo, Andrea Lopez Mato, Florence Thibaut, Simone Lista, Daniel Alcolea, Henrik Zetterberg, Kaj Blennow & Johannes Kornhuber. (2018) Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. The World Journal of Biological Psychiatry 19:4, pages 244-328.
Read now
Filippo Baldacci, Simone Lista, Enrica Cavedo, Ubaldo Bonuccelli & Harald Hampel. (2017) Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases. Expert Review of Proteomics 14:4, pages 285-299.
Read now

Articles from other publishers (53)

Qian Wang, Sijue Tao, Lei Xing, Jiuyu Liu, Cankun Xu, Xinyi Xu, Haohan Ding, Qi Shen, Xiaobo Yu & Yingwei Zheng. (2023) SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease. European Journal of Medical Research 28:1.
Crossref
SiLu Yan, XiaoLi Yang & Jürgen Kurths. (2023) Abnormalities of rhythms and phase lag index in the data-driven cortical network model of Alzheimer's disease. Nonlinear Dynamics 111:22, pages 21289-21306.
Crossref
Rebecca Grønning, Anna Jeppsson, Per Hellström, Katarina Laurell, Dan Farahmand, Henrik Zetterberg, Kaj Blennow, Carsten Wikkelsø & Mats Tullberg. (2023) Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus. Fluids and Barriers of the CNS 20:1.
Crossref
Feng Gao, Fang Li, Jianhao Wang, Hang Yu, Xiang Li, Hongyu Chen, Jiabei Wang, Dongdong Qin, Yiyi Li, Songyan Liu, Xi Zhang & Zhi-Hao Wang. (2023) SERS-Based Optical Nanobiosensors for the Detection of Alzheimer’s Disease. Biosensors 13:9, pages 880.
Crossref
Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Julia Doroszkiewicz, Renata Borawska, Agnieszka Słowik, Henrik Zetterberg, Jörg Hanrieder, Kaj Blennow & Barbara Mroczko. (2023) The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease. International Journal of Molecular Sciences 24:17, pages 13166.
Crossref
Yanan Xu, Hailun Jiang, Bin Zhu, Mingnan Cao, Tao Feng, Zhongshi Sun, Guanhua Du & Zhigang Zhao. (2023) Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease. CNS Neuroscience & Therapeutics 29:8, pages 2060-2073.
Crossref
Shital Rani, Sudhrita Basu Dhar, Akhil Khajuria, Dikshi Gupta, Pradeep Kumar Jaiswal, Neha Singla, Mandeep Kaur, Gurpal Singh & Ravi Pratap Barnwal. (2023) Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease. Cellular and Molecular Neurobiology 43:6, pages 2491-2523.
Crossref
Lily Zhang, Yanjie Zhou, Liu Yang, Yue Wang & Zheman Xiao. (2023) PACAP6-38 improves nitroglycerin-induced central sensitization by modulating synaptic plasticity at the trigeminal nucleus caudalis in a male rat model of chronic migraine. The Journal of Headache and Pain 24:1.
Crossref
Deepika Negi, Simon Granak, Susan Shorter, Valerie B. O’Leary, Ivan Rektor & Saak V. Ovsepian. (2023) Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases. Neurotherapeutics 20:3, pages 767-778.
Crossref
Poonam Sharma, Princi Thapak, Bhawana Chandwani, Harsha Kharkwal, G. T. Kulkarni, Rajendra Awasthi & Bhupesh Sharma. 2023. Deciphering Drug Targets for Alzheimer’s Disease. Deciphering Drug Targets for Alzheimer’s Disease 125 149 .
Kirsten E. J. Wesenhagen, Betty M. Tijms, Lynn Boonkamp, Patty L. Hoede, Julie Goossens, Nele Dewit, Philip Scheltens, Eugeen Vanmechelen, Pieter Jelle Visser & Charlotte E. Teunissen. (2022) P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles. Alzheimer's Research & Therapy 14:1.
Crossref
Dong Cui, Han Li, Pengxiang Liu, Guanghua Gu, Xiaoli Li, Lei Wang & Shimin Yin. (2022) Analysis of the neural mechanism of spectra decrease in MCI by a thalamo-cortical coupled neural mass model. Journal of Neural Engineering 19:6, pages 066043.
Crossref
Anabel Alba-González, Julián Yáñez, Ramón Anadón & Mónica Folgueira. (2022) Neurogranin-like immunoreactivity in the zebrafish brain during development. Brain Structure and Function 227:8, pages 2593-2607.
Crossref
Daniella Castro Araújo, Adriano Alonso Veloso, Karina Braga Gomes, Leonardo Cruz de Souza, Nivio Ziviani & Paulo Caramelli. (2022) A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer’s Disease. Journal of Alzheimer's Disease 88:2, pages 549-561.
Crossref
Tao-Ran Li, Qin Yang, Xiaochen Hu & Ying Han. (2022) Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage. Current Neuropharmacology 20:4, pages 713-737.
Crossref
Kaixuan Luo, Yuhong Wang, Wen-Shiang Chen, Xiangjun Feng, Yehui Liao, Shaochun Chen, Yao Liu, Chengde Liao, Moxian Chen & Lijuan Ao. (2022) Treatment Combining Focused Ultrasound with Gastrodin Alleviates Memory Deficit and Neuropathology in an Alzheimer’s Disease-Like Experimental Mouse Model. Neural Plasticity 2022, pages 1-13.
Crossref
Masood Sadiq Butt, Urwa Tariq, Iahtisham‐Ul‐Haq, Ambreen Naz & Muhammad Rizwan. (2021) Neuroprotective effects of oleuropein: Recent developments and contemporary research. Journal of Food Biochemistry 45:12.
Crossref
Si Qi Yoong, Jinhua Lu, Huimin Xing, Bibek Gyanwali, Yue Qian Tan & Xi Vivien Wu. (2021) The prognostic utility of CSF neurogranin in predicting future cognitive decline in the Alzheimer’s disease continuum: A systematic review and meta-analysis with narrative synthesis. Ageing Research Reviews 72, pages 101491.
Crossref
Rokeya Akter, Habibur Rahman, Tapan Behl, Mohammad Arifur Rahman Chowdhury, Mohammad Manirujjaman, Israt Jahan Bulbul, Shimaa E. Elshenaw, Delia Mirela Tit & Simona Bungau. (2021) Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases. CNS & Neurological Disorders - Drug Targets 20:5, pages 430-450.
Crossref
Shu Xu, Yanbo Zhang, Zhiqing Xu & Luping Song. (2021) Effect of the cPKCγ-Ng Signaling System on Rapid Eye Movement Sleep Deprivation-Induced Learning and Memory Impairment in Rats. Frontiers in Psychiatry 12.
Crossref
Gülüzar ÖZBOLAT & Ares ALİZADE. (2021) IN VITRO STUDIES ON THE PROTECTIVE EFFECT OF TANNIC ACID OF U87 CELLS INDUCED BY BETA-AMYLOID. Journal of Basic and Clinical Health Sciences 5:3, pages 213-217.
Crossref
Ye-Eun Yoo, Seungjoon Lee, Woohyun Kim, Hyosang Kim, Changuk Chung, Seungmin Ha, Jinsu Park, Yeonseung Chung, Hyojin Kang & Eunjoon Kim. (2021) Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice. Frontiers in Molecular Neuroscience 14.
Crossref
Dan Xu, Ping Yang, Zhang-Jian Yang, Qiu-Gen Li, Ye-Tong Ouyang, Ting Yu, Jian-Hui Shangguan, Yu-Ying Wan, Li-Ping Jiang, Xin-Hui Qu & Xiao-Jian Han. (2021) Blockage of Drp1 phosphorylation at Ser579 protects neurons against Aβ1‑42‑induced degeneration. Molecular Medicine Reports 24:3.
Crossref
Wen-wen Lian, Wei Zhou, Bao-yue Zhang, Hao Jia, Lv-jie Xu, Ai-lin Liu & Guan-hua Du. (2020) DL0410 ameliorates cognitive disorder in SAMP8 mice by promoting mitochondrial dynamics and the NMDAR-CREB-BDNF pathway. Acta Pharmacologica Sinica 42:7, pages 1055-1068.
Crossref
Li Gao, Jianmei Li, Ming Yan & Maimaiti Aili. (2021) Methylation factor MRPL15 identified as a potential biological target in Alzheimer’s disease. Aging 13:10, pages 13560-13570.
Crossref
Roberta Cascella & Cristina Cecchi. (2021) Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis. International Journal of Molecular Sciences 22:9, pages 4914.
Crossref
Amanda Cano, Patric Turowski, Miren Ettcheto, Jason Thomas Duskey, Giovanni Tosi, Elena Sánchez-López, Maria Luisa García, Antonio Camins, Eliana B. Souto, Agustín Ruiz, Marta Marquié & Mercè Boada. (2021) Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges. Journal of Nanobiotechnology 19:1.
Crossref
Julia Remnestål, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, Anna Zettergren, Silke Kern, Ingmar Skoog, Peter Nilsson & Anna Månberg. (2021) Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds. Alzheimer's Research & Therapy 13:1.
Crossref
Donovan A. McGrowder, Fabian Miller, Kurt Vaz, Chukwuemeka Nwokocha, Cameil Wilson-Clarke, Melisa Anderson-Cross, Jabari Brown, Lennox Anderson-Jackson, Lowen Williams, Lyndon Latore, Rory Thompson & Ruby Alexander-Lindo. (2021) Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives. Brain Sciences 11:2, pages 215.
Crossref
André S. L. M. Antunes, Valéria de Almeida, Fernanda Crunfli, Victor C. Carregari & Daniel Martins-de-Souza. 2021. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders 251 264 .
Eva Ausó, Violeta Gómez-Vicente & Gema Esquiva. (2020) Biomarkers for Alzheimer’s Disease Early Diagnosis. Journal of Personalized Medicine 10:3, pages 114.
Crossref
Chiara Villa, Marialuisa Lavitrano, Elena Salvatore & Romina Combi. (2020) Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights. Journal of Personalized Medicine 10:3, pages 61.
Crossref
Mei Xue, Fu-Rong Sun, Ya-Nan Ou, Xue-Ning Shen, Hong-Qi Li, Yu-Yuan Huang, Qiang Dong, Lan Tan & Jin-Tai Yu. (2020) Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease. Aging 12:10, pages 9365-9379.
Crossref
Patrizia A. Chiesa, Marion Houot, Andrea Vergallo, Enrica Cavedo, Simone Lista, Marie Claude Potier, Henrik Zetterberg, Kaj Blennow, Eugeen Vanmechelen, Ann De Vos, Bruno Dubois & Harald Hampel. (2020) Association of brain network dynamics with plasma biomarkers in subjective memory complainers. Neurobiology of Aging 88, pages 83-90.
Crossref
Alice Bittar, Nemil Bhatt & Rakez Kayed. (2020) Advances and considerations in AD tau-targeted immunotherapy. Neurobiology of Disease 134, pages 104707.
Crossref
Julian Pohlan, Bernd A. Leidel & Tobias Lindner. 2020. Biomarkers for Traumatic Brain Injury. Biomarkers for Traumatic Brain Injury 211 219 .
Tao-Ran Li, Xiao-Ni Wang, Can Sheng, Yu-Xia Li, Frederic Zhen-Tao Li, Yu Sun & Ying Han. (2019) Extracellular vesicles as an emerging tool for the early detection of Alzheimer’s disease. Mechanisms of Ageing and Development 184, pages 111175.
Crossref
S. Bulgakova, P. Romanchuk, N. Romanchuk, V. Pyatin, D. Romanov & A. Volobuev. (2019) Alzheimer’s Disease and Artificial Intelligence: Long-term Personalized Rehabilitation and Medical and Social Support. Bulletin of Science and Practice 5:11, pages 136-175.
Crossref
Nicola Toschi, Simone Lista, Filippo Baldacci, Enrica Cavedo, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan J. Teipel, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Remy Genthon, Marie-Odile Habert, Bruno Dubois, Roberto Floris, Francesco Garaci, Andrea Vergallo, Harald Hampel, Hovagim Bakardjian, Habib Benali, Hugo Bertin, Joel Bonheur, Laurie Boukadida, Nadia Boukerrou, Enrica Cavedo, Patrizia Chiesa, Olivier Colliot, Bruno Dubois, Marion Dubois, Stéphane Epelbaum, Geoffroy Gagliardi, Remy Genthon, Marie-Odile Habert, Harald Hampel, Marion Houot, Aurélie Kas, Foudil Lamari, Marcel Levy, Simone Lista, Christiane Metzinger, Fanny Mochel, Francis Nyasse, Catherine Poisson, Marie-Claude Potier, Marie Revillon, Antonio Santos, Katia Santos Andrade, Marine Sole, Mohmed Surtee, Michel Thiebaut de Schotten, Andrea Vergallo & Nadjia Younsi. (2019) Biomarker-guided clustering of Alzheimer's disease clinical syndromes. Neurobiology of Aging 83, pages 42-53.
Crossref
Liu Shi, Sarah Westwood, Alison L. Baird, Laura Winchester, Valerija Dobricic, Fabian Kilpert, Shengjun Hong, Andre Franke, Abdul Hye, Nicholas J. Ashton, Angharad R. Morgan, Isabelle Bos, Stephanie J.B. Vos, Noel J. Buckley, Mara ten Kate, Philip Scheltens, Rik Vandenberghe, Silvy Gabel, Karen Meersmans, Sebastiaan Engelborghs, Ellen E. De Roeck, Kristel Sleegers, Giovanni B. Frisoni, Olivier Blin, Jill C. Richardson, Régis Bordet, José L. Molinuevo, Lorena Rami, Anders Wallin, Petronella Kettunen, Magda Tsolaki, Frans Verhey, Alberto Lleó, Daniel Alcolea, Julius Popp, Gwendoline Peyratout, Pablo Martinez‐Lage, Mikel Tainta, Peter Johannsen, Charlotte E. Teunissen, Yvonne Freund‐Levi, Lutz Frölich, Cristina Legido‐Quigley, Frederik Barkhof, Kaj Blennow, Henrik Zetterberg, Susan Baker, B. Paul Morgan, Johannes Streffer, Pieter Jelle Visser, Lars Bertram, Simon Lovestone & Alejo J. Nevado‐Holgado. (2019) Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimer's & Dementia 15:11, pages 1478-1488.
Crossref
Shuang Liang, Zijian Wang, Jiaqi Yuan, Jing Zhang, Xueling Dai, Fei Qin, Jiayu Zhang & Yaxuan Sun. (2019) Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-β1-42 Induced Alzherimer’s Disease Rat Model using UHPLC-Q-Exactive Qrbitrap Mass Spectrometry. Molecules 24:14, pages 2584.
Crossref
Seongju Lee, Sakulrat Mankhong & Ju-Hee Kang. (2019) Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges. International Journal of Molecular Sciences 20:7, pages 1728.
Crossref
Hua Zhang, Joseph Therriault, Min Su Kang, Kok Pin Ng, Tharick A. Pascoal, Pedro Rosa-Neto & Serge Gauthier. (2018) Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease. Alzheimer's Research & Therapy 10:1.
Crossref
Fausto Chiazza, Harald Tammen, Hiranya Pintana, Grazyna Lietzau, Massimo Collino, Thomas Nyström, Thomas Klein, Vladimer Darsalia & Cesare Patrone. (2018) The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway. Cardiovascular Diabetology 17:1.
Crossref
José Luis Molinuevo, Scott Ayton, Richard Batrla, Martin M. Bednar, Tobias Bittner, Jeffrey Cummings, Anne M. Fagan, Harald Hampel, Michelle M. Mielke, Alvydas Mikulskis, Sid O’Bryant, Philip Scheltens, Jeffrey Sevigny, Leslie M. Shaw, Holly D. Soares, Gary Tong, John Q. Trojanowski, Henrik Zetterberg & Kaj Blennow. (2018) Current state of Alzheimer’s fluid biomarkers. Acta Neuropathologica 136:6, pages 821-853.
Crossref
Harald Hampel, Sid E. O’Bryant, José L. Molinuevo, Henrik Zetterberg, Colin L. Masters, Simone Lista, Steven J. Kiddle, Richard Batrla & Kaj Blennow. (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews Neurology 14:11, pages 639-652.
Crossref
Boris SabirzhanovAlan I. FadenTaryn AubrechtRebecca HenryEthan GlaserBogdan A. Stoica. (2018) MicroRNA-711–Induced Downregulation of Angiopoietin-1 Mediates Neuronal Cell Death. Journal of Neurotrauma 35:20, pages 2462-2481.
Crossref
Yudong Zhang, Shuihua Wang, Yuxiu Sui, Ming Yang, Bin Liu, Hong Cheng, Junding Sun, Wenjuan Jia, Preetha Phillips & Juan Manuel Gorriz. (2018) Multivariate Approach for Alzheimer’s Disease Detection Using Stationary Wavelet Entropy and Predator-Prey Particle Swarm Optimization. Journal of Alzheimer's Disease 65:3, pages 855-869.
Crossref
Francis Herman, Susan Westfall, Justin Brathwaite & Giulio M. Pasinetti. (2018) Suppression of Presymptomatic Oxidative Stress and Inflammation in Neurodegeneration by Grape-Derived Polyphenols. Frontiers in Pharmacology 9.
Crossref
Harald Hampel, Andrea Vergallo, Filippo Sean Giorgi, Seung Hyun Kim, Herman Depypere, Manuela Graziani, Amira Saidi, Robert Nisticò & Simone Lista. (2018) Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification. Frontiers in Neuroendocrinology 50, pages 31-51.
Crossref
Harald Hampel, Nicola Toschi, Claudio Babiloni, Filippo Baldacci, Keith L. Black, Arun L.W. Bokde, René S. Bun, Francesco Cacciola, Enrica Cavedo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Maria-Teresa Ferretti, Nathalie George, Remy Genthon, Marie-Odile Habert, Karl Herholz, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Jean Lorenceau, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Craig Ritchie, Simone Rossi, Emiliano Santarnecchi, Olaf Sporns, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Erfan Younesi, Francesco Garaci & Simone Lista. (2018) Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. Journal of Alzheimer's Disease 64:s1, pages S47-S105.
Crossref
Harald Hampel, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan J. Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Remy Genthon, Bruno Dubois, Roberto Floris, Francesco Garaci & Simone Lista. (2018) Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐40 . Alzheimer's & Dementia 14:4, pages 492-501.
Crossref
Andrea Vergallo, Cecilia Carlesi, Cristina Pagni, Filippo Sean Giorgi, Filippo Baldacci, Lucia Petrozzi, Roberto Ceravolo, Gloria Tognoni, Gabriele Siciliano & Ubaldo Bonuccelli. (2017) A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting. Neurological Sciences 38:10, pages 1791-1797.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.